Download presentation
Presentation is loading. Please wait.
Published bySurya Budiman Modified over 5 years ago
1
Prevalence of gBRCA1/2 mutations stratified by (A) FIGO stage, and (B) family history of cancer.
Prevalence of gBRCA1/2 mutations stratified by (A) FIGO stage, and (B) family history of cancer. In panel (A), three patients with a FIGO stage of ‘other’ were not included in the analysis. FIGO, International Federation of Gynecology and Obstetrics; gBRCA, germline BRCA. Takayuki Enomoto et al. Int J Gynecol Cancer 2019;29: © IGCS and ESGO Re-use permitted under CC BY. Published by BMJ.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.